BioCatalystWatch
HROWWorkspace / HROW / OverviewCompany library
Price
Market cap
Next catalystExpected Q4 2026NATACYN · Data readoutCompany release ↗
Cash

Chart & Events

Candle interval

Core Clinical

BYQLOVI

PreINDP1P2P3FilingApproved
Upcoming / outlook

TRIESENCE®

PreINDP1P2P3FilingApproved
Upcoming / outlook

MELT-210 / YOCHIL™

PreINDP1P2P3FilingApproved
Upcoming / outlook

H-N08

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

OPUVIZ

VEGF

PreINDP1P2P3FilingApproved
Upcoming / outlook

NATACYN

Upcoming / outlook

  • Timing and evidence

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

BYQLOVI

PreINDP1P2P3FilingApproved
Upcoming / outlook

NATACYN

Upcoming / outlook

  • Timing and evidence

H-N08

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

OPUVIZ

VEGF

PreINDP1P2P3FilingApproved
Upcoming / outlook

MELT-210 / YOCHIL™

PreINDP1P2P3FilingApproved
Upcoming / outlook

TRIESENCE®

PreINDP1P2P3FilingApproved
Upcoming / outlook

Other pipelines

NATACYN

Approved / commercial

OPUVIZ

VEGF

Approved

PreINDP1P2P3FilingApproved
TRIESENCE®

Approved

PreINDP1P2P3FilingApproved
OPUVIZ

VEGF

Approved

PreINDP1P2P3FilingApproved
TRIESENCE®

Approved

PreINDP1P2P3FilingApproved
OPUVIZ

VEGF

Approved

PreINDP1P2P3FilingApproved
TRIESENCE®

Approved

PreINDP1P2P3FilingApproved
TRIESENCE®

Approved

PreINDP1P2P3FilingApproved
TRIESENCE®

Approved

PreINDP1P2P3FilingApproved

History / paused

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

HROW SEC archive